glutathione treatment and parkinson& 39 Randomized, double‐blind, pilot evaluation of intravenous in Parkinson's disease - Hauser - 2009 - Movement Disorders Recent advances in dopaminergic strategies

- Minoxidil (for scalp)

M.McGowanA.ONeillC.CotterT

Pharmacologic strategies of increasing NK-recognition of SCLC cells, including epigenetic regulators, could sensitize the tumor cells to therapeutic agents and to T-cell killing ( in vitro ( These studies confirm that there is significant benefit to adding PD1/PD-L1 inhibitors to first-line chemotherapy in extensive stage SCLC, while also underscoring the importance of investigating epigenetic regulators in SCLC

The abundant iron-sulfur (FeS) compounds found in such environments are capable of ( i ) catalyzing other redox reactions (e.g., N 2 to NH 3 or NO 3 )[16]

van der MeijEHMastHvan der WaalI

Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom